N

Neurocrine Biosciences
D

NBIX

120.710
USD
4.63
(3.99%)
مغلق
حجم التداول
115,877
الربح لكل سهم
5
العائد الربحي
-
P/E
37
حجم السوق
12,035,212,744
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.350
    (-1.73%)
    19.940 USD
    A
    ALKS
    -0.240
    (-0.68%)
    35.260 USD
    A
    AVDL
    -0.05500
    (-0.65%)
    8.41000 USD
    E
    ESPR
    -0.03500
    (-1.88%)
    1.82500 USD
    I
    INSM
    -2.480
    (-2.97%)
    81.040 USD
    S
    SAGE
    0.16000
    (2.24%)
    7.30500 USD
    S
    SRPT
    -2.010
    (-1.86%)
    106.280 USD
    TEVA
    TEVA
    -0.255
    (-1.50%)
    16.745 USD
    المزيد
الأخبار
المقالات

العنوان: Neurocrine Biosciences

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.